Projected Income Statement: RH

Forecast Balance Sheet: RH

Forecast Balance Sheet - RH
Fiscal Period: January 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 22.4 937 2,367 2,594 2,378 2,087 1,687 1,253
Change - 4,083.04% 152.61% 9.59% -8.33% -12.23% -19.17% -25.73%
Announcement Date 3/29/22 3/29/23 3/27/24 4/2/25 3/31/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: RH

Fiscal Period: January 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 185.4 173.6 269.4 230.8 199.8 223.4 171.4 179.8
Change - -6.33% 55.12% -14.32% -13.41% 11.8% -23.3% 4.93%
Free Cash Flow (FCF) 1 476.7 230 -67.14 -213.7 252.4 214.7 186.2 213.5
Change - -51.75% -129.19% -218.27% 218.11% -14.94% -13.25% 14.63%
Announcement Date 3/29/22 3/29/23 3/27/24 4/2/25 3/31/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: RH

Fiscal Period: January 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 28.93% 25.91% 18.19% 16.95% 17.34% 15.59% 15.97% 17.64%
EBIT Margin (%) 25.61% 22% 13% 11.26% 11.38% 9.31% 10.49% 11.79%
EBT Margin (%) 22.09% 12.24% 5.5% 2.79% 4.85% 4.14% 5.84% 8.04%
Net margin (%) 18.32% 14.72% 4.21% 2.28% 3.63% 3.68% 4.3% 4.75%
FCF margin (%) 12.68% 6.41% -2.22% -6.72% 7.34% 5.91% 4.69% 4.95%
FCF / Net Income (%) 69.24% 43.52% -52.64% -295.11% 202.26% 160.46% 109.06% 104.28%

Profitability

        
ROA 18.17% 9.74% 2.7% 1.66% 2.66% 2.44% 3.78% 7.7%
ROE 94.79% 54.08% 52.36% - - 67.88% 44.29% 38.85%

Financial Health

        
Leverage (Debt/EBITDA) 0.02x 1.01x 4.3x 4.81x 3.99x 3.68x 2.66x 1.65x
Debt / Free cash flow 0.05x 4.07x -35.26x -12.14x 9.42x 9.72x 9.06x 5.87x

Capital Intensity

        
CAPEX / Current Assets (%) 4.93% 4.84% 8.89% 7.26% 5.81% 6.15% 4.31% 4.17%
CAPEX / EBITDA (%) 17.05% 18.66% 48.89% 42.81% 33.5% 39.42% 27.01% 23.64%
CAPEX / FCF (%) 38.89% 75.48% -401.17% -108% 79.18% 104.07% 92.02% 84.23%

Items per share

        
Cash flow per share 1 21.28 15.2 9.362 0.8551 22.85 18.51 15.39 -
Change - -28.58% -38.4% -90.87% 2,572.27% -19% -16.84% -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 55.02 33.36 -16.24 -8.736 3.22 8.086 13.85 25.34
Change - -39.37% -148.68% 46.2% 136.86% 151.11% 71.32% 82.95%
EPS 1 22.13 19.9 5.91 3.62 6.31 6.887 7.827 10.29
Change - -10.08% -70.3% -38.75% 74.31% 9.15% 13.65% 31.51%
Nbr of stocks (in thousands) 21,469 23,064 18,219 18,603 18,778 18,933 18,933 18,933
Announcement Date 3/29/22 3/29/23 3/27/24 4/2/25 3/31/26 - - -
1USD
Estimates
2027 *2028 *
P/E 16.4x 14.4x
PBR 14x 8.16x
EV / Sales 1.16x 0.96x
Yield - -

EPS & Dividend

EPS & Dividend - RH


Y-o-Y evolution of P/E

Valuation ratios - P/E - RH
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - RH
Trader
Investor
Global
Quality
-
ESG MSCI
-
MarketScreener Ratings - RH
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
112.99USD
Average target price
165.82USD
Spread / Average Target
+46.76%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - RH